参考文献/References:
[1]Ensrud KE,Crandall CJ.Osteoporosis[J].Ann Intern Med,2017,167(3):ITC17-ITC32. [2]Wang L,Yu W,Yin X,et al.Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study[J].JAMA Netw Open,2021,4(8):e2121106. [3]Yang RZ,Xu WN,Zheng HL,et al.Exosomes derived from vascular endothelial cells antagonize glucocorticoid-induced osteoporosis by inhibiting ferritinophagy with resultant limited ferroptosis of osteoblasts[J].J Cell Physiol,2021,236(9):6691-6705. [4]Edelmann MJ,Kima PE.Current understanding of extracellular vesicle homing/tropism[J].Zoonoses (Burlingt),2022,2:14. [5]Zhou B,Xu K,Zheng X,et al.Application of exosomes as liquid biopsy in clinical diagnosis[J].Signal Transduct Target Ther,2020,5(1):144. [6]Pegtel DM,Gould SJ.Exosomes[J].Annu Rev Biochem,2019,88:487-514. [7]Chen BY,Sung CW,Chen C,et al.Advances in exosomes technology[J].Clin Chim Acta,2019,493:14-19. [8]Kalluri R,LeBleu VS.The biology, function, and biomedical applications of exosomes[J].Science,2020,367(6478):eaau6977. [9]Lai JJ,Chau ZL,Chen SY,et al.Exosome Processing and Characterization Approaches for Research and Technology Development[J].Adv Sci (Weinh),2022,9(15):e2103222. [10]Ke W,Afonin KA.Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs)[J].Adv Drug Deliv Rev,2021,176:113835. [11]杨洲,高静媛,田发明.Wnt信号通路在骨稳态中的作用[J].中国骨质疏松杂志,2022,28(1):109-113.[12]Qin Y,Sun R,Wu C,et al.Exosome: A Novel Approach to Stimulate Bone Regeneration through Regulation of Osteogenesis and Angiogenesis[J].Int J Mol Sci,2016,17(5):712. [13]Song H,Li X,Zhao Z,et al.Reversal of Osteoporotic Activity by Endothelial Cell-Secreted Bone Targeting and Biocompatible Exosomes[J].Nano Lett,2019,19(5):3040-3048. [14]Liu S,Xu X,Liang S,et al.The Application of MSCs-Derived Extracellular Vesicles in Bone Disorders: Novel Cell-Free Therapeutic Strategy[J].Front Cell Dev Biol,2020,8:619. [15]Narayanan K,Kumar S,Padmanabhan P,et al.Lineage-specific exosomes could override extracellular matrix mediated human mesenchymal stem cell differentiation[J].Biomaterials,2018,182:312-322. [16]Li Z,Wang Y,Li S,et al.Exosomes Derived From M2 Macrophages Facilitate Osteogenesis and Reduce Adipogenesis of BMSCs[J].Front Endocrinol (Lausanne),2021,12:680328. [17]Xiong Y,Chen L,Yan C,et al.M2 Macrophagy-derived exosomal miRNA-5106 induces bone mesenchymal stem cells towards osteoblastic fate by targeting salt-inducible kinase 2 and 3[J].J Nanobiotechnology,2020,18(1):66. [18]Wawrzyniak A,Balawender K.Structural and Metabolic Changes in Bone[J].Animals (Basel),2022,12(15):1946. [19]Qiu M,Zhai S,Fu Q,et al.Bone Marrow Mesenchymal Stem Cells-Derived Exosomal MicroRNA-150-3p Promotes Osteoblast Proliferation and Differentiation in Osteoporosis[J].Hum Gene Ther,2021,32(13-14):717-729. [20]Chen J,Liu M,Luo X,et al.Exosomal miRNA-486-5p derived from rheumatoid arthritis fibroblast-like synoviocytes induces osteoblast differentiation through the Tob1/BMP/Smad pathway[J].Biomater Sci,2020,8(12):3430-3442. [21]Li D,Liu J,Guo B,et al.Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation[J].Nat Commun,2016,7:10872. [22]Boyle WJ,Simonet WS,Lacey DL.Osteoclast differentiation and activation[J].Nature,2003,423(6937):337-342. [23]Guo L,Zhu Y,Li L,et al.Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1[J].Cancer Med,2019,8(12):5687-5701. [24]Kobayashi-Sun J,Yamamori S,Kondo M,et al.Uptake of osteoblast-derived extracellular vesicles promotes the differentiation of osteoclasts in the zebrafish scale[J].Commun Biol,2020,3(1):190. [25]Xiao F,Zuo B,Tao B,et al.Exosomes derived from cyclic mechanical stretch-exposed bone marrow mesenchymal stem cells inhibit RANKL-induced osteoclastogenesis through the NF-κB signaling pathway[J].Ann Transl Med,2021,9(9):798. [26]Song H,Li X,Zhao Z,et al.Reversal of Osteoporotic Activity by Endothelial Cell-Secreted Bone Targeting and Biocompatible Exosomes[J].Nano Lett,2019,19(5):3040-3048. [27]Barile L,Vassalli G.Exosomes: Therapy delivery tools and biomarkers of diseases[J].Pharmacol Ther,2017,174:63-78. [28]Zhang Y,Cai F,Liu J,et al.Transfer RNA-derived fragments as potential exosome tRNA-derived fragment biomarkers for osteoporosis[J].Int J Rheum Dis,2018,21(9):1659-1669. [29]Wei Y,Ma H,Zhou H,et al.miR-424-5p shuttled by bone marrow stem cells-derived exosomes attenuates osteogenesis via regulating WIF1-mediated Wnt/β-catenin axis[J].Aging (Albany NY),2021,13(13):17190-17201. [30]Zhang ND,Han T,Huang BK,et al.Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery[J].J Ethnopharmacol,2016,189:61-80. [31]杨傲飞.基于肾主骨生髓理论研究淫羊藿苷调控外泌体内miR-122-5p对BMSCs成骨、迁移的作用及机制[D].武汉:湖北中医药大学,2020.[32]Dong M,Wu S,Xu H,et al.FBS-Derived Exosomes as a Natural Nano-Scale Carrier for Icariin Promote Osteoblast Proliferation[J].Front Bioeng Biotechnol,2021,9:615920. [33]马笃军,彭力平,蒋顺琬,等.牛膝醇提物干预BMSC-Exos对OA模型兔局部骨组织超微结构及炎症小体的影响[J].中医药导报,2022,28(1):12-18.[34]王剑,李想,张宇,等.异补骨脂素干预后BMSCs源性外泌体调控MC3T3-E1成骨分化的研究[J].内蒙古医学杂志.2021,53(4):397-399.[35]司誉豪.龟鹿二仙胶经成骨细胞来源外泌体抗骨质疏松的作用与机制研究[D].南京:南京中医药大学,2021.[36]王礼宁.基于脂肪细胞来源外泌体研究温肾通络止痛方调控骨脂平衡抗骨质疏松的作用机制[D].南京:南京中医药大学,2021.
相似文献/References:
[1]邱梦君,郑国荣.大黄、黄连、黄芩联合三联序贯治疗Hp感染的疗效分析[J].医学信息,2018,31(06):137.[doi:10.3969/j.issn.1006-1959.2018.06.047]
QIU Meng-jun,ZHENG Guo-rong.Curative Effect Analysis of Sequential Treatment of Hp Infection by Rhubarb,Coptis Chinensis and Radix Scutellariae[J].Journal of Medical Information,2018,31(11):137.[doi:10.3969/j.issn.1006-1959.2018.06.047]
[2]黄幼玲.中药配合鹿瓜多肽治疗股骨头坏死临床效果观察[J].医学信息,2018,31(06):141.[doi:10.3969/j.issn.1006-1959.2018.06.049]
HUANG You-ling.Clinical Observation on Treatment of Femoral Head Necrosis with Chinese Medicine Combined with Lugua Polypeptide[J].Journal of Medical Information,2018,31(11):141.[doi:10.3969/j.issn.1006-1959.2018.06.049]
[3]李 扬,冯 旭,宋 舸,等.中药药性的研究方法进展[J].医学信息,2018,31(13):38.[doi:10.3969/j.issn.1006-1959.2018.13.012]
LI Yang,FENG Xu,SONG GE,et al.Progress in Research Methods of Medicinal Properties of Traditional Chinese Medicine[J].Journal of Medical Information,2018,31(11):38.[doi:10.3969/j.issn.1006-1959.2018.13.012]
[4]王慧明,卓春萍,王庆雷,等.钢板内固定术联合中药煎服治疗胫骨平台骨折的
临床疗效观察[J].医学信息,2018,31(14):110.[doi:10.3969/j.issn.1006-1959.2018.14.032]
WANG Hui-ming,ZHUO Chun-ping,WANG Qing-lei,et al.Clinical Observation on Treatment of Fracture of Tibial Plateau with Plate Internal Fixation Combined with Traditional Chinese Medicine Decoction[J].Journal of Medical Information,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.14.032]
[5]马 帅,李家斌.药物性肝损伤的临床分析[J].医学信息,2019,32(03):128.[doi:10.3969/j.issn.1006-1959.2019.03.041]
MA Shuai,LI Jia-bin.Clinical Analysis of Drug-induced Liver Injury[J].Journal of Medical Information,2019,32(11):128.[doi:10.3969/j.issn.1006-1959.2019.03.041]
[6]汪钦生,邵 敏,姜 涛.绝经后妇女中骨质疏松患者血清钙磷、骨代谢指标与BMD的关系[J].医学信息,2019,32(04):1.[doi:10.3969/j.issn.1006-1959.2019.04.001]
WANG Qin-sheng,SHAO Min,JIANG Tao.Relationship between Serum Calcium,Phosphorus and Bone Metabolism Markers and BMD in Postmenopausal Women with Osteoporosis[J].Journal of Medical Information,2019,32(11):1.[doi:10.3969/j.issn.1006-1959.2019.04.001]
[7]郑 瑜.人血白蛋白联合中药治疗卵巢过度刺激综合征患者的疗效观察[J].医学信息,2019,32(04):151.[doi:10.3969/j.issn.1006-1959.2019.04.049]
ZHENG Yu.Therapeutic Effect of Human Serum Albumin Combined with Traditional Chinese Medicine on Patients with Ovarian Hyperstimulation Syndrome[J].Journal of Medical Information,2019,32(11):151.[doi:10.3969/j.issn.1006-1959.2019.04.049]
[8]陶 源,徐俊林,陈 超.《中医方剂大辞典》胃脘痛的用药规律分析[J].医学信息,2019,32(09):161.[doi:10.3969/j.issn.1006-1959.2019.09.054]
TAO Yuan,XU Jun-lin,CHEN Chao.Analysis of the Law of Medication for Stomach Cramps in the Dictionary of Traditional Chinese Medicine Formula[J].Journal of Medical Information,2019,32(11):161.[doi:10.3969/j.issn.1006-1959.2019.09.054]
[9]江启煜,何晓华,刘秀峰,等.中药生物分子信息文献系统的研发与应用[J].医学信息,2019,32(15):10.[doi:10.3969/j.issn.1006-1959.2019.15.004]
JIANG Qi-yu,HE Xiao-hua,LIU Xiu-feng,et al.Development and Application of Traditional Chinese Medicine Biomolecular
Information Document System[J].Journal of Medical Information,2019,32(11):10.[doi:10.3969/j.issn.1006-1959.2019.15.004]
[10]谢 凡,姚佳晨,姜立群,等.中药膏方管理信息系统的构建研究[J].医学信息,2020,33(05):16.[doi:10.3969/j.issn.1006-1959.2020.05.005]
XIE Fan,YAO Jia-chen,JIANG Li-qun,et al.Research on the Construction of Traditional Chinese Medicine Ointment Management Information System[J].Journal of Medical Information,2020,33(11):16.[doi:10.3969/j.issn.1006-1959.2020.05.005]